Mary Amanda Dew1, Emily M Rosenberger, Larissa Myaskovsky, Andrea F DiMartini, Annette J DeVito Dabbs, Donna M Posluszny, Jennifer Steel, Galen E Switzer, Diana A Shellmer, Joel B Greenhouse. 1. 1 Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA. 2 Department of Psychology, University of Pittsburgh, Pittsburgh, PA. 3 Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA. 4 Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA. 5 Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA. 6 Department of Medicine, University of Pittsburgh, Pittsburgh, PA. 7 Center for Health Equity Research and Promotion, Veterans Administration Pittsburgh Healthcare System, Pittsburgh, PA. 8 Department of Surgery, University of Pittsburgh, Pittsburgh, PA. 9 Department of Acute and Tertiary Care, University of Pittsburgh School of Nursing, Pittsburgh, PA. 10 Department of Statistics, Carnegie Mellon University, Pittsburgh, PA.
Abstract
BACKGROUND: Depression and anxiety are common mental health problems in transplant populations. There is mixed evidence concerning whether they increase morbidity and mortality risks after transplantation. If such associations exist, additional risk reduction strategies may be needed. METHODS: Four bibliographic databases were searched from 1981 through September 2014 for studies prospectively examining whether depression or anxiety (determined with diagnostic evaluations or standardized symptom scales) affected risk for posttransplant mortality, graft loss, acute graft rejection, chronic rejection, cancer, infection, and rehospitalization. RESULTS: Twenty-seven studies (10 heart, total n = 1738; 6 liver, n = 1063; 5 kidney, n = 49515; 4 lung, n = 584; 1 pancreas, n = 80; 1 mixed recipient sample, n = 205) were identified. In each, depression and/or anxiety were typically measured before or early after transplantation. Follow-up for outcomes was a median of 5.8 years (range, 0.50-18.0). Depression increased the relative risk (RR) of mortality by 65% (RR, 1.65; 95% confidence interval [95% CI], 1.34-2.05; 20 studies). Meta-regression indicated that risk was stronger in studies that did (vs did not) control for potential confounders (P = .032). Risk was unaffected by type of transplant or other study characteristics. Depression increased death-censored graft loss risk (RR, 1.65; 95% CI, 1.21-2.26, 3 studies). Depression was not associated with other morbidities (each morbidity was assessed in 1-4 studies). Anxiety did not significantly increase mortality risk (RR, 1.39; 95% CI, 0.85-2.27, 6 studies) or morbidity risks (assessed in single studies). CONCLUSIONS: Depression increases risk for posttransplant mortality. Few studies considered morbidities; the depression-graft loss association suggests that linkages with morbidities deserve greater attention. Depression screening and treatment may be warranted, although whether these activities would reduce posttransplant mortality requires study.
BACKGROUND:Depression and anxiety are common mental health problems in transplant populations. There is mixed evidence concerning whether they increase morbidity and mortality risks after transplantation. If such associations exist, additional risk reduction strategies may be needed. METHODS: Four bibliographic databases were searched from 1981 through September 2014 for studies prospectively examining whether depression or anxiety (determined with diagnostic evaluations or standardized symptom scales) affected risk for posttransplant mortality, graft loss, acute graft rejection, chronic rejection, cancer, infection, and rehospitalization. RESULTS: Twenty-seven studies (10 heart, total n = 1738; 6 liver, n = 1063; 5 kidney, n = 49515; 4 lung, n = 584; 1 pancreas, n = 80; 1 mixed recipient sample, n = 205) were identified. In each, depression and/or anxiety were typically measured before or early after transplantation. Follow-up for outcomes was a median of 5.8 years (range, 0.50-18.0). Depression increased the relative risk (RR) of mortality by 65% (RR, 1.65; 95% confidence interval [95% CI], 1.34-2.05; 20 studies). Meta-regression indicated that risk was stronger in studies that did (vs did not) control for potential confounders (P = .032). Risk was unaffected by type of transplant or other study characteristics. Depression increased death-censored graft loss risk (RR, 1.65; 95% CI, 1.21-2.26, 3 studies). Depression was not associated with other morbidities (each morbidity was assessed in 1-4 studies). Anxiety did not significantly increase mortality risk (RR, 1.39; 95% CI, 0.85-2.27, 6 studies) or morbidity risks (assessed in single studies). CONCLUSIONS:Depression increases risk for posttransplant mortality. Few studies considered morbidities; the depression-graft loss association suggests that linkages with morbidities deserve greater attention. Depression screening and treatment may be warranted, although whether these activities would reduce posttransplant mortality requires study.
Authors: R A Maricle; J D Hosenpud; D J Norman; G A Pantely; A M Cobanoglu; A Starr Journal: J Heart Lung Transplant Date: 1991 Nov-Dec Impact factor: 10.247
Authors: J P Singer; P P Katz; A Soong; P Shrestha; D Huang; J Ho; M Mindo; J R Greenland; S R Hays; J Golden; J Kukreja; M E Kleinhenz; R J Shah; P D Blanc Journal: Am J Transplant Date: 2017-01-03 Impact factor: 8.086
Authors: Michael A Freeman; John R Pleis; Kellee R Bornemann; Emilee Croswell; Mary Amanda Dew; Chung-Chou H Chang; Galen E Switzer; Anthony Langone; Anuja Mittal-Henkle; Somnath Saha; Mohan Ramkumar; Jareen Adams Flohr; Christie P Thomas; Larissa Myaskovsky Journal: Transplantation Date: 2017-06 Impact factor: 4.939
Authors: Ana Ayesta; María Teresa Vidán Astiz; María Jesús Valero Masa; Javier Segovia; María Dolores García Cosío; Manuel Martínez-Sellés Journal: Clin Cardiol Date: 2018-03-25 Impact factor: 2.882
Authors: Rebecca M Saracino; Devika R Jutagir; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon Journal: J Pain Symptom Manage Date: 2018-03-08 Impact factor: 3.612
Authors: Jonathan M Konel; Fatima Warsame; Hao Ying; Christine E Haugen; Alexandra Mountford; Nadia M Chu; Deidra C Crews; Niraj M Desai; Jacqueline M Garonzik-Wang; Jeremy D Walston; Silas P Norman; Dorry L Segev; Mara A McAdams-DeMarco Journal: Clin Transplant Date: 2018-09-23 Impact factor: 2.863
Authors: Lu Hu; Annette DeVito Dabbs; Mary Amanda Dew; Susan M Sereika; Jennifer H Lingler Journal: Clin Transplant Date: 2017-06-11 Impact factor: 2.863
Authors: Nicholas A Kolaitis; Allison Soong; Pavan Shrestha; Hanjing Zhuo; John Neuhaus; Patti P Katz; John R Greenland; Jeffrey Golden; Lorriana E Leard; Rupal J Shah; Steven R Hays; Jasleen Kukreja; Mary Ellen Kleinhenz; Paul D Blanc; Jonathan P Singer Journal: J Thorac Cardiovasc Surg Date: 2018-02-22 Impact factor: 5.209